Vanguard Group Inc Abeona Therapeutics Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,966,023 shares of ABEO stock, worth $9.85 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,966,023
Previous 2,007,626
2.07%
Holding current value
$9.85 Million
Previous $12.7 Million
14.01%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ABEO
# of Institutions
68Shares Held
28.6MCall Options Held
631KPut Options Held
2.9K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.9MShares$19.6 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$18.5 Million0.85% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.53MShares$17.7 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.12MShares$10.6 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA2.08MShares$10.4 Million7.9% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $29.8M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...